AI with intent: How Inizio is redefining pharma through precision and partnership
October 29, 2025 | Intelligent Commercialization
At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the future of Intelligent Commercialization™.
Empowering human insight at Fierce Pharma Week
This year’s Fierce Pharma Week brought together the leading voices shaping the future of pharmaceutical communications, strategy, and innovation. At Inizio, we had a front-row seat through the contributions of experts, who showcased how we’re combining human expertise with AI to deliver precision, credibility, and measurable impact.
Across every discussion our experts took part in, one theme stood out: AI delivers its greatest value when guided by intent. From elevating scientific storytelling to advancing field medical enablement and enabling data-driven decision-making, our teams demonstrated how purposeful integration of AI is transforming how pharma connects, learns, and leads.
Here’s how our experts brought that vision to life at Fierce Pharma Week through connected insight, practical innovation, and partnership that drives real-world change.
Engineering credibility in an AI-powered world
In the session “From earned to engineered,” Inizio Evoke’s Will Reese, Theresa Dolge, and Kelly Cusumano urged pharma communicators to rethink visibility in an AI-shaped world.
They discussed the rise of “thin” versus “thick” content, concise, discoverable insights that feed AI models versus deeply sourced narratives that build authority. The strongest brands balance both, ensuring that what AI learns is accurate, credible, and humanly resonant.
As Will noted, “AI rewards content that’s structured, traceable, and solution-oriented.” The key is designing material that both humans and machines can trust, because what’s visible shapes what’s believed.
Explore the full talk delivered by Inizio Evoke here.
Building real capability with real impact
AI delivers the most value when guided by experts who use it with purpose.
Inizio Medical’s Kelly Malloy, SVP of Customer Engagement for AI and Augmented Intelligence, brought this to life during her talk, “The business case for next-gen field medical enablement,” alongside a panel of industry leaders:
- Tiffanie Stewart, PhD, Senior Director, MSLs, Inizio Engage
- Donnie Wooten, Jr., PharmD, Senior Director, Global Medical Capabilities – Oncology, AstraZeneca
- Michael Kahn, formerly Senior Director, Medical Affairs Operations Leader, Spark Therapeutics
Using tools like MSL Interact, teams can rehearse realistic HCP conversations in a safe, simulated environment. It’s a powerful example of using AI to enhance human skills like empathy, curiosity, and dialogue, rather than aiming to replace them. The panel highlighted the value of adaptive, continuous learning along with a “Four Ps” model: prepare, practice, perform, pivot.
“Generative AI is an accelerant, not a shortcut,” Kelly reminded the audience. “When used deliberately, it bridges science and storytelling- helping field teams communicate more clearly and confidently in the moments that matter most.”
Watch the full talk delivered by Inizio Medical here.
Transforming medical affairs with data and AI
Inizio Advisory’s session, “Precision Medical Affairs in action,” led by Lori Klein, Partner, Medical Affairs Practice Lead, brought together expert insights from:
- Nikheel Kolatkar, VP, US Medical, Genentech
- Loucif Ouyahia, Global Head of Digital Healthcare, Jazz Pharmaceuticals
They described how precision Medical Affairs moves from reactive to predictive by using AI-driven analytics to uncover care gaps, localize insights, and personalize scientific engagement, connecting data across functions to create continuous feedback loops, and equip teams to partner confidently with AI.
As Lori summarized, “When you integrate human and machine intelligence, you don’t just find new insights – you create new impact.”
Watch Inizio Advisory’s Fierce Pharma Week session here.
Precision launch: aligning data, strategy, and purpose
In their second session, “Precision launch: Integrating data and AI to power commercial and medical strategy,” Inizio Advisory’s Jo-Ann Saitta, Partner, Global Data Strategy, and Lori Klein, spotlighted the value of data unity and strategic alignment.
Through centralized, compliant products like ClarityNav, part of the Navigator AI™ pharma teams can align next-best actions, understand the voice of the customer, and orchestrate personalized engagements. When medical and commercial teams operate from a single, trusted source of truth, every insight becomes actionable, and every action measurable.
This is what modern launch excellence looks like: predictive, connected, and powered by purpose.
Watch Inizio Advisory’s second Fierce Pharma Week session here.
Innovation rooted in the human equation
Every session echoed one essential truth: AI is only as valuable as the people guiding it. Whether in content, training, or analytics, Inizio’s approach to innovation is grounded in the belief that technology should elevate human creativity rather than eclipse it.
We’re building systems that help decision-makers within healthcare and pharma:
- See more clearly
- Decide more precisely
- Act with greater purpose
Because empathy, curiosity, and expertise, not algorithms, sustain trust in healthcare.
From insight to impact with Intelligent Commercialization™
Fierce Pharma Week reinforced our mission: to lead the future of Intelligent Commercialization™ – where human insight, data, and AI converge to deliver clarity, speed and measurable impact.
- Through strategic intelligence, Navigator AI™ enables faster, smarter portfolio and investment decisions, sharpens strategy, strengthens field execution, and accelerates launches.
- Through medical intelligence, iON.AI™ converts scientific evidence into actionable insights that enhance the influence and effectiveness of Medical Affairs execution.
- Through commercial intelligence, Cognitev™ translates primary generated behavioral data into activation – fueling omnichannel engagement, optimizing field force strategy, and aligning tactics across the lifecycle.
Together, we help the industry move beyond insight to action through accelerating launches, sharpening strategies, and driving real-world impact across the full lifecycle of commercialization.
Ready to unlock the power of Intelligent Commercialization™ across your organization?
Let’s talk about how using AI with intent can elevate your strategy, accelerate impact, and drive smarter engagement across the product lifecycle. Connect with our experts here.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Wargaming in HCV
The challenge:Our client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of...
Living with Lupus: Breaking the Silence
Published in eyeforpharma July 2017 by Mariel Metcalfe
Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research
One of the biggest buzz topics in the global health community over the last couple of years has been human-centred design, also referred to as behaviour-centred design. In this blog...
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global...
TRIO OF HIRES SIGNAL PEGASUS’ NORTHERN GRIT
Growth trend continues at ‘health first, sector second’ agencyPegasus, an Ashfield company, part of UDG Healthcare plc, has announced further growth of its Pharma and Life Sciences division with the...
PEGASUS SCOOPS EXCELLENCE IN INTEGRATED PRODUCT/BRAND COMMUNICATIONS AT COMMUNIQUÉ 2017
Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the Excellence In Integrated Product/Brand Communications award at the 2017 Communiqué awards for its work with...
EphMRA 2017 round up
We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Taking a hybrid qualitative-quantitative approach to research
Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr...
20th anniversary celebrations
We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/
Pharma CI Asia Conference & Exhibition 2017
13-14 July 2017, Singapore